100% Quality Guarantee
PhD-Level Technical Support
Key Features

APC Anti-Human CD133 Antibody [W6B3C1] (AGEL3044)

SKU AGEL3044
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FCM
Reactivity Human
Host Species Mouse
Isotype Mouse IgG1, κ
Clone W6B3C1
Conjugation APC
$178 - $772

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

APC Anti-Human CD133 Antibody [W6B3C1]

The CD133 Monoclonal Antibody (W6B3C1) offered by Assaygenie is a premium research tool designed for the detection and analysis of CD133, a key marker for cancer stem cells and progenitor cells. This high-quality antibody, derived through a monoclonal antibody production process, is specifically targeted for human samples and is ideal for a range of applications including immunofluorescence, flow cytometry, and immunohistochemistry.CD133, also known as prominin-1, is a transmembrane glycoprotein that has been linked to crucial functions in stem cell biology and tumorigenesis. Its expression is often associated with tumor-initiating cells in various types of cancers, making it a valuable target for cancer research and therapeutic development.

The CD133 Monoclonal Antibody (W6B3C1) provides researchers with a reliable tool for studying the role of CD133 in cancer progression, metastasis, and treatment resistance.By using this antibody, researchers can gain valuable insights into the presence and distribution of CD133 in different cellular contexts, facilitating a deeper understanding of its biological functions and potential clinical relevance. The CD133 Monoclonal Antibody (W6B3C1) from Assaygenie empowers researchers to advance their studies in oncology, regenerative medicine, and stem cell biology, offering a precise and sensitive tool for investigating the role of CD133 in health and disease.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose